Cargando…

Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow

The latest global outbreak of 2019 respiratory coronavirus disease (COVID-19) is triggered by the inception of novel coronavirus SARS-CoV2. If recent events are of any indicators of the epidemics of past, it is undeniable to state a fact that the SARS-CoV2 viral infection is highly transmissible wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parmar, Paritosh, Rao, Priyashi, Sharma, Abhilasha, Shukla, Arpit, Rawal, Rakesh M., Saraf, Meenu, Patel, Baldev V., Goswami, Dweipayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130811/ https://www.ncbi.nlm.nih.gov/pubmed/34008129 http://dx.doi.org/10.1007/s11030-021-10233-3

Ejemplares similares

Identifying structural–functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation
por: Rao, Priyashi, et al.
Publicado: (2021)

Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M(pro)) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation
por: Rao, Priyashi, et al.
Publicado: (2020)

Perceiving SARS-CoV-2 Mpro and PLpro dual inhibitors from pool of recognized antiviral compounds of endophytic microbes: an in silico simulation study
por: Prajapati, Jignesh, et al.
Publicado: (2022)

Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation
por: Patel, Rohit, et al.
Publicado: (2021)

Exemplifying an archetypal thorium-EPS complexation by novel thoriotolerant Providencia thoriotolerans AM3
por: Shukla, Arpit, et al.
Publicado: (2021)

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
por: Fu, Ziyang, et al.
Publicado: (2021)

Exemplifying the next generation of antibiotic susceptibility intensifiers of phytochemicals by LasR-mediated quorum sensing inhibition
por: Shukla, Arpit, et al.
Publicado: (2021)

In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023)

Curse of La Corona: unravelling the scientific and psychological conundrums of the 21st century pandemic
por: Shukla, Arpit, et al.
Publicado: (2021)

Revealing the molecular interplay of curcumin as Culex pipiens Acetylcholine esterase 1 (AChE1) inhibitor
por: Rao, Priyashi, et al.
Publicado: (2021)

Extending the lore of curcumin as dipteran Butyrylcholine esterase (BChE) inhibitor: A holistic molecular interplay assessment
por: Rao, Priyashi, et al.
Publicado: (2022)

Molecular insights on ar-turmerone as a structural, functional and pharmacophoric analogue of synthetic mosquito repellent DEET by comprehensive computational assessment
por: Rao, Priyashi, et al.
Publicado: (2022)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation
por: Prajapati, Jignesh, et al.
Publicado: (2021)

Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
por: Sokolinskaya, Elena L., et al.
Publicado: (2022)

Probing the effects of streptomycin on Brassica napus germination and assessing its molecular interactions using extensive molecular dynamics (MD) simulations
por: Patel, Rohit, et al.
Publicado: (2023)

Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow
por: Goswami, Dweipayan
Publicado: (2021)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

A Comprehensive in vitro and in silico Assessment on Inhibition of CYP51B and Ergosterol Biosynthesis by Eugenol in Rhizopus oryzae
por: Prajapati, Jignesh, et al.
Publicado: (2022)

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
por: Tan, Jinlin, et al.
Publicado: (2022)

Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
por: Kawall, Anasha, et al.
Publicado: (2023)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
por: Ali Dahhas, Mohammed, et al.
Publicado: (2023)

NPASS: natural product activity and species source database for natural product research, discovery and tool development
por: Zeng, Xian, et al.
Publicado: (2018)

NPASS database update 2023: quantitative natural product activity and species source database for biomedical research
por: Zhao, Hui, et al.
Publicado: (2022)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
por: Lewis, Devin S. M., et al.
Publicado: (2022)

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
por: Bajaj, Teena, et al.
Publicado: (2023)

Alendronate induced chorioretinitis: The importance of meticulous assessments
por: Hassan, Muhammad, et al.
Publicado: (2019)

Characterizing and demonstrating the role of Klebsiella SSN1 exopolysaccharide in osmotic stress tolerance using neutron radiography
por: Sharma, Sheetal, et al.
Publicado: (2023)

Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Endophytic fungi: A treasure trove of novel anticancer compounds
por: Prajapati, Jignesh, et al.
Publicado: (2021)

GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023)

Tubercular intermediate uveitis: The importance of meticulous multidisciplinary assessments
por: Jayakumar, Kalaivani, et al.
Publicado: (2019)

Information communication and technology in sports: a meticulous review
por: Reyaz, Nahida, et al.
Publicado: (2023)

Abstract No.: ABS0617: Anaesthesia management of high risk cardiac patients for lower limb vascular surgeries
por: Kanzariya, Tejas
Publicado: (2022)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Evaluation and biochemical characterization of a distinctive pyoverdin from a pseudomonas isolated from chickpea rhizosphere
por: Tank, Neelam, et al.
Publicado: (2012)

Articulating the exuberant intricacies of bacterial exopolysaccharides to purge environmental pollutants
por: Mehta, Krina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qock1i2ttjvpj3omtgdb5ech8s